Methylene Blue Protocol
Low-dose methylene blue as mitochondrial enhancer and cognitive booster.
73/100
Various researchers, emerging use
Ongoing use for mitochondrial support, acute use for infections
10 phases
4 targeted
Protocol Overview
Low-dose methylene blue as mitochondrial enhancer and cognitive booster. Electron cycler that improves mitochondrial respiration. Pharmaceutical-grade USP required.
Conditions Treated
Key Resources
Safety Profile
FDA-approved for methemoglobinemia. Emerging research for cognitive enhancement, mitochondrial support, neuroprotection. Antiviral properties (inhibits virus replication). Used by biohackers. Must use pharmaceutical USP grade. Very cheap (~$20/year). Blue urine is expected. Promising but more research needed for off-label uses.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.